Patent US6562047B2 successfully refreshed from Google Patents.
EP0219782A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Use of angiotensin-converting enzyme inhibitors in the treatment of atherosclerosis, thrombosis and peripheral vascular disease
Assignee: Hoechst AG
•
Filing: 1986-10-11
•
Granted: —
•
Expires: 2006-10-11
Abstract
Abstract The preferred angiotensin converting enzyme inhibitors have the formula I <IMAGE> in which n is 1 or 2, R, R<1>, R<2> and R<3> are identical or different and each is hydrogen or an organic radical, and R<4> and R<5> form, together with the atoms carrying them, a mono-, bi- or tricyclic heterocyclic ring system. Agents containing these compounds for treating the specified diseases are also described.
Inventors
- 👤 Bernward Dr. Schölkens
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-10-23 18:23
CPC Classifications
C; C07; C07K; C07K7/00; C07K7/04; C07K7/14; A; A61; A61K; A61K38/00; A61K38/16; A61K38/55; A61K38/556; A61K31/00; A61K31/185; A61K31/19; A61K31/195; A61K31/33; A61K31/395; A61K31/40; A61K31/435; A61K31/47; A61P; A61P43/00; A61P7/00; A61P7/02; A61P9/00; A61P9/08; A61P9/10
Claims Analysis
Total Claims: 0
No claims parsed yet. Click Sync Now above to re-index claims from Google Patents.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.